xtracranial internal carotid artery (ICA) steno-occlusive disease with tandem intracranial occlusion is a major cause of acute ischemic stroke and associated with poor clinical outcome with medical management alone. 1 In 2005, a treatment strategy of acute carotid artery stenting (CAS) was suggested in patients with acute ICA occlusions (most presenting within 6 hours of symptom onset). They reported successful revascularization in 92% (23/25) of patients. 2 As revascularization of acute carotid occlusion gained acceptance as a treatment option, other groups reported their results. 3 A 2022 meta-analysis comparing acute CAS in patients with a tandem lesion, reported higher functional outcome with acute CAS (90-day modified Rankin Scale score ≤2, odds ratio, 1.52 [95% CI, 1.19-1.95]) but increased risk of symptomatic intracranial hemorrhage (odds ratio, 1.97 [95% CI, 1.23-3.15]). 4 However, this meta-analysis did not differentiate the pathophysiology of the tandem lesion by atherosclerotic versus dissection etiologies.